Framingham Study Offers Mixed Message on Galectin-3 as Heart Failure Risk ... GenomeWeb Researchers from the National Heart, Lung and Blood Institute's Framingham Heart Study have published data suggesting the protein galectin-3 could serve as a prognostic biomarker for heart failure, but the clinical utility of the marker is still uncertain. |
